Clinical Trial Update: Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India

View source ↗

Summary

This clinical trial update reports on the safety and efficacy of sofosbuvir-based regimens for chronic hepatitis C infection in real-world practice in India.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus | Status: COMPLETED